JP2025535941A5 - - Google Patents

Info

Publication number
JP2025535941A5
JP2025535941A5 JP2025523885A JP2025523885A JP2025535941A5 JP 2025535941 A5 JP2025535941 A5 JP 2025535941A5 JP 2025523885 A JP2025523885 A JP 2025523885A JP 2025523885 A JP2025523885 A JP 2025523885A JP 2025535941 A5 JP2025535941 A5 JP 2025535941A5
Authority
JP
Japan
Prior art keywords
tablet
compressible
compressed
tablet according
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025523885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025535941A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/050700 external-priority patent/WO2024096892A1/en
Publication of JP2025535941A publication Critical patent/JP2025535941A/ja
Priority to JP2025191860A priority Critical patent/JP2026027432A/ja
Publication of JP2025535941A5 publication Critical patent/JP2025535941A5/ja
Pending legal-status Critical Current

Links

JP2025523885A 2022-11-03 2022-11-22 イブタモレンの圧縮型経口製剤 Pending JP2025535941A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025191860A JP2026027432A (ja) 2022-11-03 2025-11-12 イブタモレンの圧縮型経口製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263422329P 2022-11-03 2022-11-03
US63/422,329 2022-11-03
PCT/US2022/050700 WO2024096892A1 (en) 2022-11-03 2022-11-22 Compactable oral formulations of ibutamoren

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025191860A Division JP2026027432A (ja) 2022-11-03 2025-11-12 イブタモレンの圧縮型経口製剤

Publications (2)

Publication Number Publication Date
JP2025535941A JP2025535941A (ja) 2025-10-30
JP2025535941A5 true JP2025535941A5 (https=) 2025-11-20

Family

ID=90835855

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2025523885A Pending JP2025535941A (ja) 2022-11-03 2022-11-22 イブタモレンの圧縮型経口製剤
JP2025191860A Pending JP2026027432A (ja) 2022-11-03 2025-11-12 イブタモレンの圧縮型経口製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025191860A Pending JP2026027432A (ja) 2022-11-03 2025-11-12 イブタモレンの圧縮型経口製剤

Country Status (12)

Country Link
US (2) US11969416B1 (https=)
EP (1) EP4611737A1 (https=)
JP (2) JP2025535941A (https=)
KR (1) KR20250107210A (https=)
CN (1) CN120239602A (https=)
AU (1) AU2022485048A1 (https=)
CL (1) CL2025001309A1 (https=)
CO (1) CO2025007025A2 (https=)
GE (1) GEAP202516774A (https=)
IL (1) IL320529A (https=)
MX (1) MX2025005154A (https=)
WO (1) WO2024096892A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250107210A (ko) 2022-11-03 2025-07-11 루모스 파마, 인크. 이부타모렌의 압축형 경구 제형

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US6123964A (en) 1995-10-27 2000-09-26 Merck & Co., Inc. Wet granulation formulation of a growth hormone secretagogue
AU7522896A (en) 1995-10-27 1997-05-15 Merck & Co., Inc. Wet granulation formulation of a growth hormone secretagogue
BR0113626A (pt) * 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20040005358A1 (en) * 2002-04-23 2004-01-08 Slugg Peter H. Modified-release vasopeptidase inhibitor formulation, combinations and method
EP2001475B1 (en) 2006-03-15 2018-11-14 Michael O. Thorner Methods for treating sarcopenia with a growth hormone secretagogue
FI20080351A0 (fi) 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
WO2014030204A1 (ja) * 2012-08-20 2014-02-27 大日本住友製薬株式会社 薬物含有中空粒子
CA2889499C (en) 2012-10-24 2019-09-10 Daiichi Sankyo Company, Limited Growth hormone secretagogue receptor agonists for treating amyotrophic lateral sclerosis
BR112015022398B1 (pt) * 2013-03-14 2022-01-11 Redhill Biopharma Ltd Comprimido de ondansetrona e preparação farmacêutica embalada
CA2845443A1 (en) * 2014-03-04 2015-09-04 Pharmascience Inc. Orally disintegrating tablet of nabilone and method of manufacturing
AU2016328969B2 (en) 2015-09-21 2020-10-08 Lumos Pharma, Inc. Detecting and treating growth hormone deficiency
KR20200121308A (ko) * 2018-02-14 2020-10-23 루모스 파마, 인크. 비알코올성 지방간 질환 및 비알코올성 지방간염 치료용 조성물
KR20250107210A (ko) 2022-11-03 2025-07-11 루모스 파마, 인크. 이부타모렌의 압축형 경구 제형

Similar Documents

Publication Publication Date Title
CN106943355B (zh) 药物组合物
RU2616516C2 (ru) Фармацевтическая композиция, содержащая олмесартана медоксомил и розувастатин или его соль
US5814339A (en) Film coated tablet of paracetamol and domperidone
WO2011111818A1 (ja) モサプリドまたはその塩を含む徐放型医薬組成物
WO2010140111A1 (en) Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
JP2022553313A5 (https=)
JP5208729B2 (ja) 徐放性錠剤の製造方法
WO2012018056A1 (ja) 圧縮組成物
JP2025535941A5 (https=)
JP2023536667A5 (https=)
AU2016231883B2 (en) Pharmaceutical compositions of dimethyl fumarate
JP2022540348A5 (https=)
JP7212484B2 (ja) 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法
MX2013010598A (es) Composiciones farmaceuticas de liberacion controlada de inhibidor de recaptacion de serotonina selectivo.
WO2010120963A1 (en) Tablet formulation for p38 inhibitor and method
US20060002997A1 (en) Nitrofurantoin controlled release dosage form
US20180344648A1 (en) Clobazam tablet formulation and process for its preparation
JP2024503689A5 (https=)
EP3496719B1 (en) A multi-class anti-retroviral composition
JP2021518422A (ja) レナリドミドを含む医薬組成物
JP7362302B2 (ja) レベチラセタムを含有する錠剤とその製造方法
JP5123471B2 (ja) 用量調整が容易な製剤
JP7404828B2 (ja) 経口医薬製剤およびその製造方法
JP5910311B2 (ja) 医薬錠剤およびその製造方法
JP7423297B2 (ja) 口腔内崩壊錠およびその製造方法